Related Experiment Video
Updated: Nov 1, 2025

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
Published on: September 20, 2017
Disproportionation of Pharmaceutical Salts: pHmax and Phase-Solubility/pH Variance
1in-ADME Research, 1732 First Avenue #102, New York, New York 10128, United States.
Abstract:
A multiphasic mass action equilibrium model is used to show that the critical pH in the acid-base disproportionation of a solid salt into its corresponding solid free-base form in aqueous suspensions, widely known as "pHmax", is incompletely interpreted. It is shown that the traditional thermodynamic model does not predict the invariance of pH and solubility during the salt-to-free-base conversion process in an alkalimetric titration. Rather, the conversion entails a range of pH and solubility values, depending on the amount of added excess salt above that needed to form a saturated solution. A more precise definition is proposed for pHmax (pH at the maximum solubility of a eutectic mixture), and three new terms are introduced: pHmin (pH at the minimum solubility of the eutectic mixture), pHδ (disproportionation invariant pH within the eutectic, i.e., the equilibrium pH of a spontaneously disproportionating salt slurry), and pHγ (Gibbs pH at which disproportionation yields equimolar amounts of excess salt and excess free-base solids within the eutectic). Two test compounds with reported multiple salts and the free-base solubility values were selected to illustrate the expanded concepts, the bases WR-122455 and RPR-127963. Also, dibasic calcium phosphate was selected as an ionizable test excipient. The salts are designated in the study as μ-type, when they are thermodynamically stable with respect to spontaneous disproportionation in pure water (e.g., WR-122455 salts), and δ-type, when they are predicted to spontaneously disproportionate in pure water (e.g., RPR-127963 salts). In an alkalimetric titration, when an acidified suspension of a salt of a basic molecule is titrated with a strong base (e.g., NaOH), the passage across the eutectic domain (bounded by pHmax and pHmin) is often characterized by (a) minimum in ionic strength either at pHmax (μ-type salt) or pHδ (δ-type salt) and (b) maximum buffer capacity at pHγ. When the alkalimetric titration is performed with a large excess of added salt, a wide eutectic domain forms: pHmax and pHδ remain invariant, but pHmin and pHγ shift substantially in pH. The acid-base mass action model described here can be useful in predicting the stability of salt formulations in mixtures with excipients that can act as pH modifiers.
Related Concept Videos
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Drug Dissolution: Requirements and Profile Comparison
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Factors Influencing Drug Absorption: Drug Dissolution
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
Factors Affecting Solubility

